thirty day period with 2nd-line medicines Employed in the shorter MDR-TB regimen or in whom resistance to fluoroquinolones and 2nd-line injectable agents has become excluded, a shorter MDR-TB routine of 9??12?�months could be employed as an alternative to the for a longer time regimens (Conditional recommendation, low certainty within the esti